United States · FDA National Drug Code directory
Cisatracurium besylate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65145-136_984769d6-523a-4e06-aaa7-ccbb039e38ea
- Product NDC
- 65145-136
- Form
- INJECTION
- Composition / generic term
- Cisatracurium besylate
- Labeler
- Caplin Steriles Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250117
- Source listing expiry
- 20261231
Source-listed ingredients
- CISATRACURIUM BESYLATE — 2 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, MULTI-DOSE in 1 CARTON (65145-136-01) / 10 mL in 1 VIAL, MULTI-DOSE · 65145-136-01
- 10 VIAL, MULTI-DOSE in 1 CARTON (65145-136-10) / 10 mL in 1 VIAL, MULTI-DOSE · 65145-136-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →